- Home
- /
- Treatment
- /
- Page 82
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
| Country | Product | Indication | Sponsor | Date |
|---|---|---|---|---|
|
FTV1+GDP-fucose | To improve homing to bone (treatment of myeloablation) in patients receiving hematopoietic stem cell transplantation | America Stem Cell, Inc.;11014 Bar X Trail;Helotes, Texas, 78023 | March 18, 2011 |
|
Rigosertib | Pancreatic cancer | Onconova Therapeutics, Inc;375 Pheasant Run;Newtown, Pennsylvania, 18940 | March 18, 2011 |
|
Acetyl-l-carnitine (ALC) | Rett syndrome | Leadiant Biosciences, Inc.;9841 Washingtonian Blvd., Suite 500;Gaithersburg, Maryland, 20878 | March 18, 2011 |
|
Heat Shock Protein 70 | Amyotrophic lateral sclerosis | ALS Biopharma, LLC;3805 Old Easton Rd;Doylestown, Pennsylvania, 18902 | March 18, 2011 |
|
(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide | Pancreatic Cancer | NATCO Pharma Limited;Natco House;Hyderabad 500033 | March 18, 2011 |
|
(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamide | Chronic myeloid leukemia | NATCO Pharma Limited;Natco House;Hyderbad 500033 | March 18, 2011 |
|
(3,5-Bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrimidin-2-yl amino) phenyl] benzamideNRC-AN-019 | Glioma | NATCO Pharma Limited;Natco House;Hyderbad 500033 | March 18, 2011 |
|
Brivanib alaninate | Hepatocellular Carcinoma | Bristol-Myers Squibb;P. O. Box 4000;Princeton, New Jersey, 08543 | March 18, 2011 |
|
Adeno associated viral vector containing human ARSB gene | Mucopolysaccharidosis type VI | Fondazione Telethon;Via Varese 16 - 00185 Roma; | March 17, 2011 |
|
Sar9, Met(O2)11-Substance P | Idiopathic pulmonary fibrosis | ImmuneRegen BioSciences, Inc.;IR Biosciences Holdings, Inc;Scottsdale, Arizona, 85258 | March 16, 2011 |
|
Coenzyme Q10 and d-alpha-tocopherol | Friedreich Ataxia | NBI Pharmaceuticals, Inc.;c/o Neil & Co CPAs, 1184 N. 15th Ave., Suite 1;Bozeman, Montana, 59715 | March 14, 2011 |
|
Talimogene laherparepvec | Metastatic Melanoma | BioVex, Inc. (subsidiary of Amgen);Amgen, Mail Stop 17-2-B;Thousand Oaks, California, 91320 | March 14, 2011 |
|
Eicosapentaenoic acid | Familial adenomatous polyposis | S.L.A. Pharma Ltd. (UK);Elite House, Leavesden, Watford WD25 7SA; | March 8, 2011 |
|
Acadesine | Chronic lymphocytic leukemia | Avanced In Vitro Cell Technologies, S.L.;(Advancell), 08028 Barcelona; | March 3, 2011 |
|
Adenosine triphosphate type 1 competitive inhibitor of JAK2 V617F tyrosine kinase | Myeloproliferative disorders (polycythemia vera, essential throbocythemia, and myelofibrosis) | Eli Lilly and Company;Lilly Corporate Center;Indianapolis, Indiana, 46285 | March 3, 2011 |
|
Revimmune | Autoimmune hemolytic anemia | Accentia Biopharmaceuticals;324 South Hyde Park Avenue #350;Tampa, Florida, 33606 | February 18, 2011 |
|
Acetyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-arginyl-D-cysteinyl-D-glutaminyl-D-cysteinyl-D-arginyl-D-arginyl-D-lysyl-Dasparaginylamide disulfide | Pancreatic cancer | Genus Oncology, LLC;2458 N. Racine Avenue;Chicago, Illinois, 60614 | February 18, 2011 |
|
S-59 treated FFP (plasma treated with amotosalen hydrochloride & ultraviolet A light | Thrombotic thrombocytopenic purpura | Cerus Corporation;2550 Stanwell Drive;Concord, California, 94520 | February 14, 2011 |
|
MLN4924-Inhibitor of Nedd8-activating enzyme (NAE) | Acute myeloid leukemia | Millennium Pharmaceuticals;40 Landsdowne St.;Cambridge, Massachusetts, 02139 | February 4, 2011 |
|
N-{[(5S)-3-(3-fluoro-4-thiomorpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide | Tuberculosis | Sequella, Inc.;9610 Medical Center Drive, Suite 200;Rockville, Maryland, 20820 | February 4, 2011 |
|
D-peptide | Acute myeloid leukemia | Immune System Key, Ltd;POB 23365;Jerusalem 91233 | February 4, 2011 |
|
MLN4924-Inhibitor of Nedd8-activating enzyme (NAE) | Myelodysplastic syndrome | Millennium Pharmaceuticals, Inc.;40 Landsdowne St.;Cambridge, Massachusetts, 02139 | February 4, 2011 |
|
Eflornithine | Familial adenomatous polyposis | Cancer Prevention Pharmaceuticals;1760 E. River Road #250;Tucson, Arizona, 85718 | February 4, 2011 |
|
[AC3-yCD2(V)] and Flucytosine (5-FC XR) | Glioblastoma multiforme | Tocagen, Inc.;3030 Bunker Hill St.;San Diego, California, 92109 | January 12, 2011 |
|
N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino] isonicotinamide hydrochloride | Acute myeloid leukemia | EMD Serono, Inc.;1 Technology Place;Rockland, Massachusetts, 02370 | January 12, 2011 |
